Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NSF/CCES partnership

This article was originally published in The Tan Sheet

Executive Summary

The Canadian Centre for Ethics in Sport (CCES) recognizes the NSF Certified for Sport mark on products "as a key indication that sport nutrition products have undergone stringent review" through NSF International's Athletic Banned Substances Certification Program, the organizations announce July 10. The program was also "applauded" by Canada's Minister for Sport, the Honorable Michael Chong. "While the CCES does not promote the use of supplements, we do recognize that athletes use them. Therefore, we need to assist our athletes in choosing the most trustworthy supplement products," CCES Director of Ethics & Anti-Doping Services and General Counsel Joseph de Pencier said. Major League Baseball recognized the program in March (1"The Tan Sheet" March 13, 2006, p. 11)...

You may also be interested in...

NSF Banned Athletic Substances Program Gains International Momentum

The partnership between the Canadian Centre for Ethics in Sport (CCES) and third-party testing firm NSF International has drawn the attention of several European countries, according to NSF's Kathy Jordan

Baseball Works With NSF To Offer Players Certified, Drug-Free Supplements

Major League Baseball teams will be selling players supplements certified as free of banned substances through a partnership with NSF International

Cell/Gene Therapy Is Ripe For Real-World Data Given Length Of Follow-Up Required, Abernethy Says

The former principal deputy commissioner outlined what she sees as the future data requirements for real world evidence and why cell and gene therapy will lead the way.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts